Lonza CEO Wolfgang Wienand, Samsung Biologics CEO John Rim, and Thermo Fisher CEO Marc Casper
July 23, 2025 11:00 AM EDTUpdated July 24, 11:29 AM
Pharma
Manufacturing

CD­MOs beat earn­ings ex­pec­ta­tions as clients nav­i­gate fund­ing cuts and tar­iffs

Anna Brown

News Reporter

Three CD­MOs un­veiled their lat­est earn­ings re­ports on Wednes­day – and they all seem to be singing the same tune.

Lon­za, Ther­mo Fish­er and Sam­sung …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Makary ex­pands scope of new FDA vouch­er pro­gram with first batch of re­cip­i­ents

Megarounds make a come­back as biotech starts to re­bound

Roche inks $80M up­front deal for Han­soh’s can­cer ADC

Boehringer In­gel­heim names glob­al obe­si­ty leader; Cal­i­co taps Ab­b­Vie vet for dis­cov­ery role

CHMP re­jects Sanofi’s Rezurock over clin­i­cal da­ta is­sues, but rec­om­mends BTK in­hibitor Wayrilz

sponsored

In sight: Ad­vanc­ing cell ther­a­py for reti­nal dis­ease

A service from the Financial Times